SOX9 in prostate cancer development and progression

描述（由申请人提供）：癌症经常利用发育基因/途径来维持其不受控制的生长和侵袭。为了研究前列腺癌（PCa）进展的分子机制，我们专注于重要的发育转录因子SOX 9的潜在作用。我们已经发现SOX 9在人胎儿前列腺上皮细胞和成人前列腺基底细胞中表达，表明其参与前列腺器官发生和稳态。值得注意的是，SOX 9也在体内原发性和转移性前列腺癌（PCa）中以及体外PCa细胞系中表达。其表达在激素难治性复发性PCa中进一步增加，表明SOX 9是更侵袭性PCa的潜在生物标志物。LNCaP PCa细胞中的S 0X 9过表达使得癌细胞更有效地在小鼠中建立体内异种移植物和局部侵袭。这些异种移植物积累细胞外基质（ECM）并携带巨大的血管网络，表明SOX 9通过诱导肿瘤ECM产生和血管生成来促进肿瘤生长。在LNCaP细胞中响应于SOX 9过表达的SOX 9调节基因的微阵列分析已经选择了参与细胞增殖、ECM形成和血管生成的几个潜在靶标。通过siRNA下调内源性SOX 9降低了细胞增殖，并导致PCa细胞系中细胞周期向G 0/G1转变，以及PCa异种移植物中生长减少。我们的研究进一步表明，SOX 9在PCa细胞中的表达受Wnt/2-catenin，hedgehog（Hh）和雄激素信号通路的调节，这表明SOX 9可能是前列腺发育和稳态以及PCa生长和进展的这些关键通路的重要介质。这些数据表明，SOX 9作为转录因子，调节基底细胞中表达的基因（如EMC蛋白、促血管生成因子或生长因子），这些基因对于支持正常前列腺中分泌性上皮细胞的生成或存活至关重要。在PCa中，S 0X 9表达失调允许肿瘤细胞在缺乏基底细胞支持的情况下在局部和转移部位生长。该提案的总体目标是通过鉴定和验证前列腺癌细胞系、异种移植物和患者样本中的SOX 9调节基因或途径来定义SOX 9功能的分子机制。将通过特异性上调或下调S 0X 9在PCa细胞和肿瘤中的表达来研究S 0X 9在PCa建立和生长中的功能。最后，SOX 9及其靶基因在PCa中的表达将被询问其与PCa建立和进展的相关性以及其作为预后生物标志物的潜力。本研究不仅为深入了解SOX 9在正常前列腺发育和稳态中的作用以及在PCa肿瘤发生和进展中的分子机制提供了线索。公共卫生相关性：我们将研究SOX 9在前列腺发育、维持和前列腺癌发展和进展中的功能。我们的研究结果将有助于更好地理解SOX 9功能的分子机制，并确定癌症治疗的潜在靶点。

DESCRIPTION (provided by applicant): Cancers frequently exploit developmental genes/pathways to sustain their uncontrolled growth and invasion. To study the molecular mechanisms of prostate cancer (PCa) progression, we are focusing on the potential role of SOX9, an important developmental transcription factor. We have discovered that SOX9 is expressed in human fetal prostate epithelial cells and in the basal cells of adult prostate, suggesting it is involved in prostate organogenesis and homeostasis. Significantly, SOX9 is also expressed in primary and metastatic prostate cancer (PCa) in vivo and in PCa cell lines in vitro. Its expression is further increased in hormone refractory recurrent PCa, suggesting SOX9 is a potential biomarker for more aggressive PCa. SOX9 over-expression in LNCaP PCa cell renders cancer cells more efficiently establish in vivo xenografts and local invasion in mice. These xenografts accumulates extracellular matrix (ECM) and carry a vast vascular network, suggesting SOX9 promotes tumor growth by inducing tumor ECM production and angiogenesis. Microarray analyses of SOX9 regulated genes in response to SOX9 over-expression in LNCaP cells has selected several potential targets that are involved in cell proliferation, ECM formation and angiogenesis. Down-regulation of endogenous SOX9 by siRNA decreases cell proliferation and causes a cell cycle shift to G0/G1 in PCa cell lines and a reduced growth in PCa xenografts. Our studies further show that SOX9 expression in PCa cells is regulated by the Wnt/2-catenin, hedgehog (Hh), and androgen signaling pathways, suggesting SOX9 may be an important mediator of these critical pathways for prostate development and homeostasis, and for PCa growth and progression. These data suggest that SOX9, as a transcriptional factor, regulates genes (such as EMC proteins, proangiogenic factor or growth factors) expressed in basal cells that are critical to support the generation or survival of secretory epithelial cells in normal prostate. In PCa, dysregulated SOX9 expression allows the tumor cells to grow at local and metastatic sites in the absence of basal cell support. The overall goal of this proposal is to define the molecular mechanisms of SOX9 functions by identifying and validating SOX9 regulated genes or pathways in PCa cell lines, xenografts and patient samples. SOX9 function in PCa establishment and growth will be investigated through specific up- or down-regulating SOX9 expression in PCa cells and tumors. Finally, SOX9 and its target gene expression in PCa will be interrogated for its correlation with PCa establishment and progression as well as its potential as a prognostic biomarker. This study will not only provide insight in the molecular mechanisms of SOX9 functions in development and homeostasis of normal prostate, as well as in the tumorigenesis and progression of PCa. Public Health Relevance: We will study the functions of SOX9 in prostate development, maintenance and prostate cancer development and progression. Our results will lead to a better understanding of the molecular mechanisms of SOX9 function and identify potential targets for cancer therapy.